Carolyn Gusoff has covered some of the most high profile news stories in the New York City area and is best known as a trusted, tenacious, consistent and caring voice of Long Island's concerns. For ...

FDA approved Optune Pax for locally advanced pancreatic cancer with gemcitabine/nab-paclitaxel, marking the first new modality in decades for this nonresectable ...

FDA approved Optune Pax with gemcitabine/nab-paclitaxel, applying alternating electric fields to disrupt mitosis via abdominal arrays, expanding noninvasive, home ...

A Mayo Clinic study is providing new insights into how treatment sequence can affect survival in patients with early-stage pancreatic cancer, suggesting that many patients may benefit from receiving ...

Share on Pinterest Could an experimental drug trio fight difficult-to-treat pancreatic cancer? Experiments in mouse models show promise. Image credit: adamkaz/Getty Images Pancreatic ductal ...

Current drugs for pancreatic cancer lose effectiveness within months because the tumor becomes resistant. Now, a group from Spain's National Cancer Research Centre (CNIO) has been able to avoid the ...

New research uncovered a potential new way to treat pancreatic cancer, the third-deadliest cancer in 2025. The therapy may help human immune cells more effectively attack pancreatic tumors. Below, ...

Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer. Notoriously aggressive and difficult to treat, pancreatic cancer is rarely ...

Researchers have discovered how pancreatic cancer reprograms its surroundings to spread quickly and stealthily. By using a protein called periostin, the tumor remodels nearby tissue and invades nerves ...

Spanish scientists say they have developed a potential breakthrough cure for treating pancreatic cancer, but the new therapy isn't ready for human use yet. Pancreatic cancer forms tumors in the ...

A major medical breakthrough might have been achieved while researching an eventual cure for pancreatic cancer, as a new study from scientists in Spain discovered that triple therapy could entirely ...

Adding the investigational drug elraglusib to standard first-line gemcitabine and nab-paclitaxel (GnP) may extend the lives of some patients with metastatic pancreatic ductal adenocarcinoma (PDAC), ...